Upgrade to SI Premium - Free Trial

COAG (COAG)

44.41 +0.04 (0.09%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (12/2/26)

Latest Headlines

/C O R R E C T I O N -- The Galien Foundation/ August 17, 2026 4:14 AM - PR NewsWire Form SCHEDULE 13G Hemab Therapeutics Holdi Filed by: Novo Holdings A/S August 14, 2026 5:07 PM - SEC Filing Form SCHEDULE 13G Hemab Therapeutics Holdi Filed by: Avoro Capital Advisors LLC August 14, 2026 9:02 AM - SEC Filing The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and &q August 13, 2026 9:00 AM - PR NewsWire Form SCHEDULE 13G Hemab Therapeutics Holdi Filed by: Capital International Investors August 12, 2026 10:28 AM - SEC Filing Hemab Therapeutics Holdings (COAG) PT Raised to $60 at H.C. Wainwright August 12, 2026 7:21 AM - StreetInsider Form 10-Q Hemab Therapeutics Holdi For: Jun 30 August 11, 2026 4:01 PM - SEC Filing Hemab Therapeutics Holdings (COAG) PT Raised to $58 at Jefferies August 11, 2026 3:30 PM - StreetInsider Form 8-K Hemab Therapeutics Holdi For: Aug 11 August 11, 2026 7:11 AM - SEC Filing Hemab Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update August 11, 2026 7:00 AM - StreetInsider Form SCHEDULE 13G Hemab Therapeutics Holdi Filed by: Invus Global Management, LLC August 7, 2026 9:32 AM - SEC Filing Form SCHEDULE 13G Hemab Therapeutics Holdi Filed by: FMR LLC August 6, 2026 10:28 AM - SEC Filing Form SCHEDULE 13G Hemab Therapeutics Holdi Filed by: Sofinnova Crossover II S.L.P. August 5, 2026 10:38 AM - SEC Filing Hemab shares sutacimig Phase 2 data at ISTH 2026 congress July 14, 2026 7:45 AM - StreetInsider Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress July 14, 2026 7:45 AM - StreetInsider Hemab Therapeutics Holdings (COAG) PT Raised to $47 at Jefferies July 13, 2026 8:51 AM - StreetInsider Hemab Therapeutics Holdings (COAG) PT Raised to $52 at H.C. Wainwright July 13, 2026 6:38 AM - StreetInsider Hemab shares clinical data on HMB-002, unveils HMB-003 program July 13, 2026 5:44 AM - StreetInsider Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress July 12, 2026 6:28 AM - Globe NewsWire Hemab Therapeutics to present pipeline data at ISTH 2026 June 26, 2026 9:00 AM - StreetInsider Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress June 26, 2026 9:00 AM - StreetInsider Form 4 Hemab Therapeutics Holdi For: Jun 15 Filed by: Kolchinsky Peter June 17, 2026 6:24 PM - SEC Filing H.C. Wainwright Starts Hemab Therapeutics Holdings (COAG) at Buy June 17, 2026 5:59 AM - StreetInsider Full Article List